Johnson & Johnson stock last at EUR 228.25 on October 16

Published on 10/19/2026 at 07:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Johnson & Johnson focuses on healthcare innovation. The October 16, 2026 Xetra close was EUR 228.25.

Healthcare focus and market reference

Johnson & Johnson focuses on healthcare innovation and solutions for complex diseases.
The United States is the group's home market, with the S&P 500 as its benchmark.
Johnson & Johnson's Xetra reference price was EUR 228.25 on October 16, 2026.

Close-up of a dark trading terminal screen displaying three sector charts labeled PHARMA, MED DEVICES, and CONSUMER HEALTH with green candlestick patterns, NYSE identifier visible upper right, blurred trading floor in the background under low dramatic off — Johnson notiert an der NYSE, US4781601046 Pharma Med Devices Consumer Health Charts auf Bildschirm, Illustration mit AI erstellt.

Johnson & Johnson focuses on healthcare innovation, developing solutions intended to prevent, treat and cure complex diseases. The stock's last completed Xetra session ended at EUR 228.25 on October 16, 2026.

Dated reference before the open

The EUR 228.25 closing price represents the last completed Xetra session before October 19, 2026. The first price of the day is shown from the start of trading by the continuously updated real-time quote of Johnson & Johnson stock.

The group and its market

Johnson & Johnson operates in healthcare innovation, with its investor-relations materials describing efforts focused on complex diseases and more personal, less invasive treatments. The company's home market is the United States, represented by the S&P 500 benchmark.

Market context: Market report S&P 500.

More news and analysis on Johnson & Johnson stock